THE HERALD SCOTLAND: Patients with heart failure could soon be treated at home following a world-first NHS trial at a Scots hospital.
![Scots heart patients first in world to trial new treatment](https://sqinnovation.com/wp-content/uploads/2021/10/the-herald-logo.jpg)
This novel furosemide combination product is currently under investigation and is not approved by the FDA.
THE HERALD SCOTLAND: Patients with heart failure could soon be treated at home following a world-first NHS trial at a Scots hospital.
SQ Innovation will use Ligand’s Captisol technology to achieve a smaller delivery volume for more cost-effective diuretic treatment in heart failure.
Sign up for our email list below to receive periodic updates from SQ Innovation, Inc. on the Lasix SQF Infusion as we continue development and go to market.